Pulmonx
Angela M. is an experienced professional in the healthcare industry with a focus on product management and marketing. Currently serving as Product Manager for the UK, Nordics, and Benelux at Pulmonx Corporation since January 2022, Angela has previously held leadership roles at Kapitex Healthcare Limited as Director of Marketing and Product Management and Product and Marketing Manager. Additionally, Angela worked as Key Account Manager at Avanos Medical and held several positions at Philips, including Sales Development Manager and Account Manager for Hospital Respiratory Care. Early career experiences include managing the Acute Physiotherapy Service at Airedale NHS Foundation Trust and serving as a Senior Cardiorespiratory Physiotherapist with the NHS. Angela holds an MBA from The University of Huddersfield and a BSc (Hons) in Physiotherapy from The University of Salford.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1